Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Broad Medicare Formularies Would Negatively Impact Rx Industry – PCMA

Executive Summary

Strict formulary requirements imposed on plan sponsors under the Medicare prescription drug benefit would be self-defeating for pharmaceutical manufacturers, Pharmaceutical Care Management Association CEO Mark Merritt argued Oct. 25

You may also be interested in...



Medco Says It Is Ready For Part D: Will CMS Be?

Medco is "leaning" toward participating directly in the Medicare Part D stand-alone prescription drug insurance program in 2006, CEO David Snow said during an analyst meeting Nov. 11 in Philadelphia

Medco Says It Is Ready For Part D: Will CMS Be?

Medco is "leaning" toward participating directly in the Medicare Part D stand-alone prescription drug insurance program in 2006, CEO David Snow said during an analyst meeting Nov. 11 in Philadelphia

Employer Drug Coverage Will Shift To Part D, Stakeholders Say

Employers will eventually make Medicare the source of their retirees' prescription drug coverage rather than providing it themselves, stakeholders agreed Oct. 19

Related Content

UsernamePublicRestriction

Register

LL1126271

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel